EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of a Putative SARS-CoV-2 Main Protease Inhibitor through In Silico Screening of Self-Designed Molecular Library

Nanxin Liu iD, Zeyu Yang, Yuying Liu, Xintao Dang, Qingqing Zhang, Jin Wang, Xueying Liu, Jie Zhang, Xiaoyan Pan

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241411390 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Nanxin Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, China. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Basic Research Plan in Shaanxi Province of China, Fundamental Research Funds of Xi'an Jiaotong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There have been outbreaks of SARS-CoV-2 around the world for over three years, and its variants continue to evolve. This has become a major global health threat. The main protease (Mpro, also called 3CLpro) plays a key role in viral replication and proliferation, making it an attractive drug target. Here, we have identified a novel potential inhibitor of Mpro, by applying the virtual screening of hundreds of nilotinib-structure-like compounds that we designed and synthesized. The screened compounds were assessed using SP docking, XP docking, MM-GBSA analysis, IFD docking, MD simulation, ADME/T prediction, and then an enzymatic assay in vitro. We finally identified the compound V291 as a potential SARS-CoV-2 Mpro inhibitor, with a high docking affinity and enzyme inhibitory activity. Moreover, the docking results indicate that His41 is a favorable amino acid for pi-pi interactions, while Glu166 can participate in salt-bridge formation with the protonated primary or secondary amines in the screened molecules. Thus, the compounds reported here are capable of engaging the key amino acids His41 and Glu166 in ligand-receptor interactions. A pharmacophore analysis further validates this assertion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansSARS-CoV-2Gene LibraryAminesAmino AcidsMolecular Docking SimulationProtease InhibitorsMolecular Dynamics SimulationCoronavirus 3C Proteases

Stichwörter der Autor:innen

COVID-19SARS-CoV-2 main proteaseenzymatic assayvirtual screening

Substanzen

AminesAmino AcidsProtease Inhibitors3C-like proteinase, SARS-CoV-2Coronavirus 3C Proteases

Autor:innen und Institutionen

  • School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, China.
  • School of Pharmacy, The Fourth Military Medical University, Xi'an 710032, China.

ORCID-Profile: Nanxin Liu

Förderung

  • National Natural Science Foundation of China
  • Natural Science Basic Research Plan in Shaanxi Province of China
  • Fundamental Research Funds of Xi'an Jiaotong University
  • Natural Science Basic Research Plan in the Shaanxi Province of China
  • Fundamental Research Funds of Xi’an Jiaotong University

Zitieren

APA

Liu, N., Yang, Z., Liu, Y., Dang, X., Zhang, Q., Wang, J., Liu, X., Zhang, J., & Pan, X. (2023). Identification of a Putative SARS-CoV-2 Main Protease Inhibitor through In Silico Screening of Self-Designed Molecular Library. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241411390

Vancouver

Liu N, Yang Z, Liu Y, Dang X, Zhang Q, Wang J, et al. Identification of a Putative SARS-CoV-2 Main Protease Inhibitor through In Silico Screening of Self-Designed Molecular Library. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241411390

BibTeX
@article{Liu2023,
  author = {Liu, Nanxin and Yang, Zeyu and Liu, Yuying and Dang, Xintao and Zhang, Qingqing and Wang, Jin and Liu, Xueying and Zhang, Jie and Pan, Xiaoyan},
  title = {Identification of a Putative SARS-CoV-2 Main Protease Inhibitor through In Silico Screening of Self-Designed Molecular Library},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241411390}
}
Kostenlos starten →